- Poster presentation
- Open Access
Prognostic value of right ventricular ejection fraction determined by cardiac magnetic resonance
© Ahmad et al; licensee BioMed Central Ltd. 2010
Published: 21 January 2010
Although studies have shown that right ventricular ejection fraction (RVEF) is an independent predictor of survival in patients with myocardial infarction and moderate left heart failure, there is scant data available on the prognostic significance of RVEF in patients with preserved left ventricular ejection fraction (LVEF), partly due to challenges in imaging the right ventricle (RV) due to its amorphous geometry. Recent technological advances in cardiac magnetic resonance (CMR) have allowed the RVEF to be assessed with greater accuracy.
To assess the prognostic ability of RVEF, independent of LVEF, for the development of cardiovascular outcomes: death, recurrent hospitalization and worsening CHF (New York Heart Association Class).
We prospectively evaluated 733 consecutive patients referred to our CMR center with the following indications: evaluation of left ventricular function (37%), viability (30%), valvular disease (21%), and other (12%). A comprehensive history and serologic markers (pro-BNP, Lipid profile, and CRP) were obtained on the day of the procedure. Persons blinded to patient data manually performed region of interest curves and the LVEF and RVEF were calculated via computer software analysis. Patients were divided into 4 groups: A) Normal RVEF and LVEF, B) Low RVEF and normal LVEF, C) Normal RVEF and Low LVEF, D) Low RVEF and LVEF. Normal LVEF and RVEF were considered ≥50% and RVEF ≥35%, respectively. Statistical analyses were performed using Kaplan Meier survival curves with the log-rank test and Cox regression analysis adjusting for the relevant covariates. Follow-up data were obtained via phone interview, medical records review when necessary, and the social security death index.
RVEF, independent of LVEF, predicts cardiovascular outcomes in a selected population of patients referred for CMR.
This article is published under license to BioMed Central Ltd.